An Achilles tendon rupture is a common injury with an increasing incidence during the past decade.^[@bibr10-2325967118813904],[@bibr11-2325967118813904]^ The injury is more common in men than in women, with a ratio of 1:8 to 1:10, respectively.^[@bibr14-2325967118813904],[@bibr18-2325967118813904]^ Historically, the question of surgical or nonsurgical management has been the subject of debate.^[@bibr6-2325967118813904],[@bibr33-2325967118813904]^ A recent meta-analysis of randomized controlled trials (RCTs)^[@bibr6-2325967118813904]^ reported that the risk of reruptures is almost 3 times higher in nonsurgically treated patients (9.8%) compared with those treated surgically (3.7%). Regardless of treatment, the majority of patients will suffer from reduced function compared with their preinjury status and compared with the healthy side.^[@bibr12-2325967118813904],[@bibr14-2325967118813904],[@bibr17-2325967118813904],[@bibr19-2325967118813904]^ There is limited evidence in terms of the patient-related factors that influence treatment outcomes after an acute Achilles tendon rupture. Moreover, the reasons for the large variation in outcomes, in terms of both symptoms and functional deficits, after an acute Achilles tendon rupture are still largely unknown.^[@bibr13-2325967118813904],[@bibr20-2325967118813904]^

Previous studies investigating outcomes after an acute Achilles tendon rupture have been inconclusive in terms of predictors.^[@bibr2-2325967118813904],[@bibr5-2325967118813904],[@bibr24-2325967118813904],[@bibr28-2325967118813904]^ For instance, 1 study found worse function and greater symptoms in women^[@bibr28-2325967118813904]^; another reported male sex, older age, and deep venous thrombosis as predictors of poor outcomes^[@bibr2-2325967118813904]^; and a third found that high body mass index (BMI) and older age were strong predictors of poor patient-reported outcomes.^[@bibr24-2325967118813904]^ However, these previous studies were limited by small cohort sizes, implying the need for well-controlled studies with larger cohorts.

The purpose of this study was to determine the predictors of functional and patient-reported outcomes 1 year after an acute Achilles tendon rupture using a large cohort from 2 centers. The second purpose was to determine patient characteristics for reporting within the top and bottom 10% of the Achilles tendon Total Rupture Score (ATRS) and heel-rise height outcomes. The hypothesis was that older age, higher BMI, and female sex would lead to an inferior outcome.

Methods {#section1-2325967118813904}
=======

Overall, 482 patients with an acute Achilles tendon rupture, from 5 RCTs at 2 different centers in Sweden, were included in this study. All of the RCTs were approved by regional ethical review boards in Sweden (Nos. 032-09, S617-03, 2013/1791-31/3, and 2009/2079-31/2). Of the 482 patients eligible from the different cohorts, 391 patients (83%) were included in the analysis, while 91 patients (17%) were excluded because of missing follow-up data. The results of these RCTs have been previously published.^[@bibr1-2325967118813904],[@bibr7-2325967118813904],[@bibr8-2325967118813904],[@bibr21-2325967118813904],[@bibr26-2325967118813904]^ The patient-related variables of interest were age, patient sex, smoking, treatment, and BMI. The best and worst 10% of patients for the 1-year ATRS and heel-rise height were further subanalyzed to study the predictors of their superior and inferior outcomes. A flow chart of the study is demonstrated in [Figure 1](#fig1-2325967118813904){ref-type="fig"}.

![Flowchart of included studies. ATRS, Achilles tendon Total Rupture Score.](10.1177_2325967118813904-fig1){#fig1-2325967118813904}

Cohort Descriptions {#section3-2325967118813904}
-------------------

### Nilsson-Helander et al.^[@bibr21-2325967118813904]^ {#section4-2325967118813904}

A total of 97 patients from this trial were eligible for inclusion in the present study for the 1-year follow-up. The patients were originally randomized to either surgical or nonsurgical treatment; 42 patients were treated nonsurgically, and 47 patients were treated with open repair using resorbable Kessler sutures. A below-the-knee cast with the foot in the equinus position was used for 2 weeks and then replaced by an adjustable brace (DonJoy MaxTrax ROM Walker; DJO Global) for a further 6 weeks. Weightbearing as tolerated was allowed after 6 to 8 weeks. Patients were evaluated after 1 year. From this RCT, 87 patients were included in this study.

### Olsson et al.^[@bibr25-2325967118813904]^ {#section5-2325967118813904}

A total of 100 patients, randomized to surgical or nonsurgical treatment, were eligible for inclusion in the present study. Enhanced open surgical repair using semiresorbable sutures was performed. A walking brace was used for 6 weeks postoperatively, followed by accelerated rehabilitation. All patients were allowed immediate full weightbearing and started range of motion as well as strength training 2 weeks postoperatively after initial cast immobilization. The patients in the nonsurgically treated group used the same walking brace for 8 weeks and were also allowed full immediate weightbearing. Follow-ups were performed after 1 year. A total of 88 patients from the original cohort were included in the present study.

### Domeij-Arverud et al.^[@bibr8-2325967118813904]^ {#section6-2325967118813904}

A total of 40 patients were eligible. All patients in this RCT were treated with open surgical repair using a modified Kessler technique and were subsequently randomized to 2 different postoperative protocols. The control group (26 patients) received a below-the-knee plaster cast with the ankle in 30° equinus at the outpatient clinic after the completion of surgery and were nonweightbearing with crutches during the first 2 weeks. The intervention group (21 patients) received additional treatment with adjuvant intermittent pneumatic compression (IPC) under the plaster cast for a minimum of 6 hours a day (Covidien A-V Impulse; Orthofix Vascular Novamedix). IPC was discontinued after 2 weeks. At the 2-week visit, all patients were fitted with a lower leg brace for 6 weeks (DonJoy MaxTrax ROM Walker) and were instructed to start full weightbearing. From this study, 25 surgically treated patients were included in this predictor analysis.

### Domeij-Arverud et al.^[@bibr7-2325967118813904]^ {#section7-2325967118813904}

A total of 150 patients were eligible for inclusion from this study. All patients were treated with open surgical repair using a modified Kessler technique. Postoperatively, patients were randomized to either standard plaster cast treatment or IPC (VenaFlow Elite; DJO Global) beneath a walking brace (Aircast XP Walker; DJO Global). Patients were treated with a plaster cast in a 30° equinus position and were nonweightbearing during the first 2 postoperative weeks when crutches were used. The intervention group using the brace was instructed to apply bilateral IPC during the time when they were sedentary for a minimum of 6 hours per day. The device was applied under the brace with 3 wedges, and patients were allowed to bear weight as tolerated. IPC treatment was discontinued 2 weeks postoperatively. At the 2-week visit, all patients were fitted with a lower leg brace (Aircast XP Walker) and were instructed to bear weight fully during the 6 weeks when the brace was worn. A total of 119 surgically treated patients were included in this predictor analysis.

### Svedman et al.^[@bibr31-2325967118813904]^ {#section8-2325967118813904}

A total of 95 patients from this trial were eligible for inclusion in the present study for the 1-year follow-up. All patients were treated with open surgical repair using a modified Kessler technique, and they were postoperatively randomized to either direct postoperative weightbearing in a functional brace (VACOped; OPED) with full weightbearing for 6 weeks or to nonweightbearing plaster cast immobilization for 2 weeks, followed by a brace for a further 4 weeks. A total of 72 surgically treated patients from the original cohort were included in this study.

Patient-Reported Outcomes {#section9-2325967118813904}
-------------------------

The ATRS^[@bibr22-2325967118813904]^ is a validated and injury-specific outcome tool used for patients with acute Achilles tendon ruptures.^[@bibr9-2325967118813904]^ Patients answer 10 questions that are scored from 0 to 10. A score of 0 implies significant symptoms and difficulty with physical activity, while a score of 10 implies no difficulties. Responses to the 10 items are summed to produce a total score in which the maximum is 100 points and means no difficulties at all, comparable with full recovery.

Functional Outcomes {#section10-2325967118813904}
-------------------

The functional tests were performed using a linear encoder by MuscleLab (Ergotest Innovation). The tests have been validated for examining functional outcomes in patients treated for acute Achilles tendon ruptures.^[@bibr29-2325967118813904],[@bibr30-2325967118813904]^

### Height, Number of Repetitions, and Total Work {#section11-2325967118813904}

The heel-rise test was performed with the patient standing on a 20-cm flat box with a 10° incline. The patients were asked to begin with the healthy side. They were asked to perform as many repetitions as possible in which each repetition was supposed to be performed with maximum heel-rise height. A spring-loaded string was attached to the patient's shoe to measure both height (in centimeters) and the number of repetitions. This string was in turn connected to a linear encoder unit, which recorded the measurements. The system used the patient's weight to calculate the total amount of work (*body weight* × *total distance* \[in Joules\]). When the patient was no longer able to perform an adequate heel rise, the test was stopped by the examiner. The maximum height achieved on a heel rise was also documented.

### Concentric Power {#section12-2325967118813904}

The heel-rise test was performed with the patient standing in a weight training machine and performing a single-leg heel rise. With knee flexion restricted to within 20°, patients were instructed to raise their heel as quickly and forcefully as possible. This test was repeated 3 times initially, with the patient's body weight plus 13 kg. Another 10 kg was added sequentially when an increase in power was measured, and the test was finished when a decrease in power output was noted. The maximum power (in watts) was recorded as the result. Similar to the other heel-rise test, a linear encoder was attached to the patient's shoe, and standardized equipment was used to record the test.

Statistical Analysis {#section13-2325967118813904}
--------------------

Data analysis was performed using SAS/STAT version 14.2 (SAS Institute). Continuous variables were described as mean, standard deviation, median, and range, and categorical variables were described as count (n) and proportion (%). The results from the tests of muscle function were reported as the limb symmetry index (LSI), defined as the ratio between the involved limb score and the uninvolved limb score and expressed as a percentage (*result of involved*/*result of uninvolved* × 100 = LSI). For comparisons between included and excluded patients, the Fisher exact test (lowest 1-sided *P* value multiplied by 2) for dichotomous variables and the Mann-Whitney *U* test for continuous variables were performed. Distributions of outcomes were checked with box plots. In cases of nonlinear distribution, Spearman rho was used to determine correlations between predictors and outcomes. In addition, outcomes were compared with the Mann-Whitney *U* test stratified by the dichotomous predictor. Linear regression modeling was performed to analyze the effect of patient demographics on the LSI of the different tests of muscle function.

The results of linear regression were reported as beta estimates, 95% CIs, and *P* values. The *R* ^2^ value was given as a measurement of the goodness-of-fit model. The likelihood of reporting in the top or bottom 10% of the ATRS and LSI of heel-rise height was analyzed with binary regression modeling. Patient demographics and treatment were used as independent variables. The results of the binary regression models were presented as odds ratios (ORs), 95% CIs, and *P* values. An OR was expressed for every unit increase in the predictor variable. All significance tests were 2-sided and conducted at the 5% significance level. Forward stepwise multivariate regression modeling was planned in cases in which more than 1 predictor was found to be significant.

Results {#section14-2325967118813904}
=======

The mean age of the 391 patients included in this study was 40.4 years (range, 18-71 years), 17% were women, and 79% of the cohort was treated with surgery. No differences in baseline demographics were found between the included and excluded patients ([Table 1](#table1-2325967118813904){ref-type="table"}).

###### 

Demographics of Eligible Participants

![](10.1177_2325967118813904-table1)

  Variable                      Total (N = 482)       Included (n = 391)    Excluded (n = 91)     *P* Value
  ----------------------------- --------------------- --------------------- --------------------- -----------
  Patient sex, n (%)                                                                              .41
   Male                         398 (82.6)            326 (83.4)            72 (79.1)             
   Female                       84 (17.4)             65 (16.6)             19 (20.9)             
  Age, y                                                                                          .65
   n                            481                   391                   90                    
   Mean ± SD                    40.3 ± 8.5            40.4 ± 8.7            39.6 ± 7.7            
   Median (range)               40.0 (17.0-71.0)      39.0 (18.0-71.0)      40.5 (17.0-62.0)      
  Height, cm                                                                                      .30
   n                            446                   380                   66                    
   Mean ± SD                    178.3 ± 8.6           178.5 ± 8.6           177.2 ± 8.6           
   Median (range)               180.0 (153.0-200.0)   180.0 (153.0-200.0)   178.0 (154.0-191.0)   
  Weight, kg                                                                                      .77
   n                            447                   381                   66                    
   Mean ± SD                    83.7 ± 13.2           83.7 ± 13.1           83.8 ± 14.2           
   Median (range)               84.0 (50.2-129.0)     84.0 (52.0-129.0)     85.0 (50.2-110.0)     
  Body mass index, kg/m^2^                                                                        .53
   n                            446                   380                   66                    
   Mean ± SD                    26.3 ± 3.3            26.2 ± 3.3            26.6 ± 3.7            
   Median (range)               25.8 (19.5-43.6)      25.7 (19.6-43.6)      25.8 (19.5-39.4)      
  Smoking, n (%)                                                                                  .33
   Nonsmoker                    350 (93.6)            284 (94.4)            66 (90.4)             
   Smoker                       24 (6.4)              17 (5.6)              7 (9.6)               
  Treatment, n (%)                                                                                .24
   Surgical                     384 (79.7)            307 (78.5)            77 (84.6)             
   Nonsurgical                  98 (20.3)             84 (21.5)             14 (15.4)             
  Inclusion/exclusion, n (%)                                                                      
   Included                     391 (81.1)            391 (100.0)           0 (0.0)               
   Excluded, outcomes unknown   91 (18.9)             0 (0.0)               91 (100.0)            

Achilles Tendon Total Rupture Score {#section15-2325967118813904}
-----------------------------------

The mean 1-year ATRS was 81.3 ± 18.9. Because of the nonlinear distribution of the ATRS, regression analysis was not considered appropriate. No significant correlations were found between the 1-year ATRS and baseline demographics. In addition, no significant differences in patient-reported or functional outcomes were found for BMI, between sexes, smokers and nonsmokers, or type of treatment.

Heel-Rise Height {#section16-2325967118813904}
----------------

The mean 1-year LSI of heel-rise height was 83% ± 19%. At 1 year postoperatively, the LSI of heel-rise height decreased by around 4% for every 10-year increment in age (beta, --3.94 \[95% CI, --6.19 to --1.69\]; *P* = .0006). In addition, a nonsignificant relationship toward a superior LSI of heel-rise height was found in patients treated with surgery compared with nonsurgical treatment (beta, --4.49 \[95% CI, --9.14 to 0.16\]; *P* = .058) ([Appendix Table A1](#table2-2325967118813904){ref-type="table"} and [Figure 2](#fig2-2325967118813904){ref-type="fig"}).

![Linear regression models, odds ratios, and 95% CIs for the limb symmetry index of heel-rise height. BMI, body mass index.](10.1177_2325967118813904-fig2){#fig2-2325967118813904}

Concentric Power {#section17-2325967118813904}
----------------

The mean 1-year LSI of concentric power during the heel-rise test was 83.3% ± 31.9%. No variable was found to be significant when attempting to predict the 1-year LSI of concentric power from the heel-rise test ([Appendix Table A2](#table3-2325967118813904){ref-type="table"} and [Figure 3](#fig3-2325967118813904){ref-type="fig"}).

![Linear regression models, odds ratios, and 95% CIs for the limb symmetry index of concentric power. BMI, body mass index.](10.1177_2325967118813904-fig3){#fig3-2325967118813904}

Total Work {#section18-2325967118813904}
----------

The mean LSI of total work during the heel-rise test was 73.6% ± 32.1%. No variable was found to be significant when attempting to predict the 1-year LSI of total work from the heel-rise test ([Appendix Table A3](#table4-2325967118813904){ref-type="table"} and [Figure 4](#fig4-2325967118813904){ref-type="fig"}).

![Linear regression models, odds ratios, and 95% CIs for the limb symmetry index of total work. BMI, body mass index.](10.1177_2325967118813904-fig4){#fig4-2325967118813904}

Number of Repetitions {#section19-2325967118813904}
---------------------

The mean 1-year LSI of number of repetitions was 89.4% ± 23.5%. No variable was found to be significant when attempting to predict the 1-year LSI of total number of repetitions from the heel-rise test ([Appendix Table A4](#table5-2325967118813904){ref-type="table"} and [Figure 5](#fig5-2325967118813904){ref-type="fig"}).

![Linear regression models, odds ratios, and 95% CIs for the limb symmetry index of number of repetitions. BMI, body mass index.](10.1177_2325967118813904-fig5){#fig5-2325967118813904}

Top 10% of the ATRS {#section20-2325967118813904}
-------------------

No variable was found to be significant when attempting to predict reporting in the top 10% of the ATRS 1 year after an Achilles tendon rupture ([Appendix Table A5](#table6-2325967118813904){ref-type="table"} and [Figure 6](#fig6-2325967118813904){ref-type="fig"}).

![Logistic regression models, odds ratios (ORs), and 95% CIs for patients in the top 10% of the Achilles tendon Total Rupture Score. BMI, body mass index.](10.1177_2325967118813904-fig6){#fig6-2325967118813904}

Bottom 10% of the ATRS {#section21-2325967118813904}
----------------------

No variable was found to be significant when attempting to predict reporting in the bottom 10% of the ATRS 1 year after an Achilles tendon rupture ([Appendix Table A6](#table7-2325967118813904){ref-type="table"} and [Figure 7](#fig7-2325967118813904){ref-type="fig"}).

![Logistic regression models, odds ratios (ORs), and 95% CIs for patients in the bottom 10% of the Achilles tendon Total Rupture Score. BMI, body mass index.](10.1177_2325967118813904-fig7){#fig7-2325967118813904}

Top 10% of Heel-Rise Height {#section22-2325967118813904}
---------------------------

No variable was found to be significant when attempting to predict reporting in the top 10% of the LSI of heel-rise height 1 year after an Achilles tendon rupture ([Appendix Table A7](#table8-2325967118813904){ref-type="table"} and [Figure 8](#fig8-2325967118813904){ref-type="fig"}).

![Logistic regression models, odds ratios (ORs), and 95% CIs for patients in the top 10% of the limb symmetry index of heel-rise height. BMI, body mass index.](10.1177_2325967118813904-fig8){#fig8-2325967118813904}

Bottom 10% of Heel-Rise Height {#section23-2325967118813904}
------------------------------

A 1.79-fold increase in the odds of being in the bottom 10% of the LSI of heel-rise height 1 year after an Achilles tendon rupture was found for every 10-year increment in age (*P* = .0026) ([Appendix Table A8](#table9-2325967118813904){ref-type="table"} and [Figure 9](#fig9-2325967118813904){ref-type="fig"}).

![Logistic regression models, odds ratios (ORs), and 95% CIs for patients in bottom 10% of the limb symmetry index of heel-rise height. BMI, body mass index.](10.1177_2325967118813904-fig9){#fig9-2325967118813904}

Discussion {#section24-2325967118813904}
==========

The most important finding of this study is that older age at the time of injury predicted a poorer 1-year functional outcome after an acute Achilles tendon rupture; that is, the odds of achieving a more symmetrical heel-rise height became progressively worse with increasing age at the time of injury. There was also a nonsignificant relationship for surgically treated patients to experience greater recovery of heel-rise height in comparison with nonsurgically treated patients. No differences in functional outcomes could be identified between the sexes or in patients with a higher BMI. None of the studied factors were seen to significantly affect patient-reported outcomes.

The finding in the present study of a poorer functional outcome related to aging is in agreement with previous predictor studies of patients after acute Achilles tendon ruptures.^[@bibr2-2325967118813904],[@bibr24-2325967118813904]^ The decrease in heel-rise height found among older patients may be explained by degenerative changes related to age and changes in collagen synthesis, leading to increased stiffness.^[@bibr32-2325967118813904]^ The mechanisms suggested to contribute to tendon changes with age are the formation of advanced glycation end-product crosslinks, an aging stem cell population, reactive oxygen species, and cellular senescence.^[@bibr4-2325967118813904]^

Patient age was, however, not a risk factor for inferior results in the ATRS, which suggests that despite poorer recovery of the patients' heel-rise height, this outcome did not imply poorer subjective recovery. It can be hypothesized that as patients grow older, they lower their expectations and reduce their demands for lower limb function, which might be reflected by their ATRS.

Older age at the time of an Achilles tendon rupture was a strong negative predictor of inferior heel-rise height in the present study, but it was not able to predict a poorer outcome for any of the other studied functional variables or for the patient-reported ATRS. Because age is a nonmodifiable factor, it might be especially important to thoroughly evaluate the optimal treatment regimen in the older patient population. Each patient's expectations and functional demands should therefore be incorporated in the treatment algorithm, including surgical repair and postoperative rehabilitation.

It is not known whether differences in postoperative rehabilitation or modifications in the surgical techniques employed could be attributed to the observed age-related poor heel-rise height. However, a clear trend toward a more symmetrical heel-rise height was shown for surgically treated patients in this study compared with nonsurgically treated patients. This is possibly because surgically treated tendon ruptures may have less of a likelihood of elongation, as the surgeon has the opportunity to appose the ends of the ruptured tendon closely at the time of surgery; however, this has yet to be proven in the literature. Elongation of the tendon is known to lead to poorer outcomes, and an elongated tendon is related to a lower heel-rise height. If surgery is able to predict a better heel-rise height, it may then be important for patients with high physical demands to be surgically treated to maximize the chance of a better outcome.

Fortunately, smoking is rare in patients who sustain an Achilles tendon rupture. The injury mainly affects active men between the ages of 35 and 45 years, and the prevalence of smoking in this group is very low.^[@bibr21-2325967118813904]^ This explains why only 17 smokers were included in the present analysis. Data on smoking were, however, missing in 90 patients, as this was not part of the study protocol, and it may have influenced the proportion of smokers found in the cohort and the results of the analyses. It is surprising that smoking did not predict a poorer outcome in any of the analyzed measures, as it is often reported to be a negative predictor of outcomes for other orthopaedic injuries, such as rotator cuff ruptures and spinal surgery.^[@bibr11-2325967118813904],[@bibr15-2325967118813904],[@bibr27-2325967118813904]^

The question of whether patient sex plays a role in outcomes after an acute Achilles tendon rupture has been much debated, as previous predictor studies have reported conflicting results.^[@bibr2-2325967118813904],[@bibr3-2325967118813904],[@bibr24-2325967118813904],[@bibr28-2325967118813904]^ To the best of our knowledge, no previous predictive model has included as many women as the present study. This is likely because of the nature of the incidence of this injury, which primarily affects male patients. In this study, patient sex did not predict any of the 4 tested outcomes, nor did it influence the analyses of superior and inferior outcomes. This finding is important, as it can provide insight into why previous results are conflicting, and it is likely that patient sex should not be regarded as a predictor of outcomes.

The finding in this study that BMI did not affect outcomes is in disagreement with earlier studies.^[@bibr16-2325967118813904],[@bibr23-2325967118813904]^ Olsson et al^[@bibr24-2325967118813904]^ concluded that a high BMI predicted a worse ATRS at both 6 and 12 months, but no correlation was found with heel-rise height.

As the optimal treatment is still very much open to debate, it is important to evaluate predictors that can help to guide the physician in deciding a management strategy. Including goodness-of-fit analysis in the study adds additional strength compared with previous predictor studies of acute Achilles tendon ruptures. However, it should be emphasized that the regression models in this study were limited by the overall poor capacity of the models to predict the dependent outcome because none of the *R* ^2^ values was higher than 0.03 and results from area under the receiver operating characteristic curve analyses were no better than chance. This implies that there are other important aspects of treatment that affect the outcomes in these patients. There has been an increased focus on individualized treatment after acute Achilles tendon ruptures in recent years, which requires a deeper understanding of factors contributing to variations in outcome. Potentially, the current outcome measures are not sensitive enough to provide us with the answers necessary for improving therapy. For instance, there is a considerable ceiling effect for the ATRS.^[@bibr22-2325967118813904]^ A further limitation of the present study is the multiple univariate regression analyses that were performed, which results in a risk of mass significance and questions the small number of significant findings in this study. Unfortunately, no multivariate models could be performed because of the small number of factors that affected outcomes. The use of multivariate models would have allowed for a more in-depth analysis in which explicit subgroups of patients could have been studied. Finally, this study is limited by the fact that the patients were included from previous RCTs, with different surgical methods and rehabilitation protocols, which entails a risk of transfer bias.

Conclusion {#section25-2325967118813904}
==========

Older age at the time of injury negatively affected heel-rise height 1 year after an Achilles tendon rupture. Irrespective of age, a nonsignificant relationship toward the superior recovery of heel-rise height was seen in patients treated surgically. None of the factors studied affected patient-reported outcomes.
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###### 

Linear Regression Model With the LSI of Heel-Rise Height as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table2)

  Tentative Predictor                  n             Mean LSI        Beta (95% CI)               *P* Value   *R* ^2^ Value
  ------------------------------------ ------------- --------------- --------------------------- ----------- ---------------
  Patient sex                          Missing: 0                    1.21 (--4.21 to 6.63)       .66         0.00
   Male                                314           81.12 ± 15.25                                           
   Female                              57            82.33 ± 33.41                                           
  Age (beta per 10 units), y           Missing: 0                    --3.94 (--6.19 to --1.69)   .0006       0.03
   18 to \<35                          92            84.71 ± 14.21                                           
   35 to \<45                          167           83.07 ± 22.14                                           
   45 to \<55                          88            76.19 ± 14.97                                           
   55 to 71                            24            74.80 ± 22.03                                           
  Height (beta per 10 units), cm       Missing: 11                   --0.37 (--2.73 to 1.99)     .76         0.00
   153.0 to \<175.0                    111           81.14 ± 26.22                                           
   175.0 to \<183.0                    124           80.08 ± 13.32                                           
   183.0 to 200.0                      127           82.47 ± 16.81                                           
  Weight (beta per 10 units), kg       Missing: 10                   --0.37 (--1.93 to 1.19)     .64         0.00
   52.0 to \<78.0                      117           82.07 ± 25.65                                           
   78.0 to \<90.0                      122           80.27 ± 14.54                                           
   90.0 to 129.0                       124           81.42 ± 15.96                                           
  Body mass index (derived), kg/m^2^   Missing: 11                   --0.11 (--0.75 to 0.52)     .73         0.00
   19.6 to \<25.0                      146           80.90 ± 15.88                                           
   25.0 to \<30.0                      172           81.85 ± 22.46                                           
   30.0 to 43.6                        44            80.01 ± 15.60                                           
  Smoking                              Missing: 90                   --0.94 (--12.07 to 10.19)   .87         0.00
   Nonsmoker                           268           82.01 ± 20.72                                           
   Smoker                              14            81.07 ± 18.55                                           
  Treatment                            Missing: 0                    --4.49 (--9.14 to 0.16)     .058        0.01
   Surgery                             287           82.33 ± 20.30                                           
   Nonsurgery                          84            77.83 ± 13.94                                           

*^a^*All tests were performed with univariate linear regression. Beta, *P* value, and *R* ^2^ value are based on original values and not on stratified groups. LSI, limb symmetry index.

###### 

Linear Regression Model With the LSI of Concentric Power as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table3)

  Tentative Predictor                  n             Mean LSI        Beta (95% CI)             *P* Value   *R* ^2^ Value
  ------------------------------------ ------------- --------------- ------------------------- ----------- ---------------
  Patient sex                          Missing: 0                    2.60 (--6.38 to 11.58)    .57         0.00
   Male                                308           82.92 ± 29.23                                         
   Female                              58            85.52 ± 43.52                                         
  Age (beta per 10 units), y           Missing: 0                    0.07 (--3.74 to 3.88)     .97         0.00
   18 to \<35                          90            83.22 ± 28.42                                         
   35 to \<45                          165           84.86 ± 34.04                                         
   45 to \<55                          86            78.50 ± 26.91                                         
   55 to 71                            25            90.33 ± 42.58                                         
  Height (beta per 10 units), cm       Missing: 11                   1.77 (--2.14 to 5.68)     .37         0.00
   153.0 to \<175.0                    108           83.06 ± 36.32                                         
   175.0 to \<183.0                    122           81.72 ± 27.55                                         
   183.0 to 200.0                      126           86.25 ± 31.49                                         
  Weight (beta per 10 units), kg       Missing: 10                   0.42 (--2.20 to 3.05)     .75         0.00
   52.0 to \<78.0                      116           83.88 ± 37.33                                         
   78.0 to \<90.0                      120           82.46 ± 27.74                                         
   90.0 to 129.0                       121           84.82 ± 29.73                                         
  Body mass index (derived), kg/m^2^   Missing: 11                   --0.16 (--1.25 to 0.93)   .77         0.00
   19.6 to \<25.0                      145           83.51 ± 31.92                                         
   25.0 to \<30.0                      168           84.19 ± 33.45                                         
   30.0 to 43.6                        43            82.71 ± 24.20                                         
  Smoking                              Missing: 90                   2.68 (--15.82 to 21.18)   .78         0.00
   Nonsmoker                           265           82.94 ± 33.56                                         
   Smoker                              13            85.62 ± 19.58                                         
  Treatment                            Missing: 0                    3.04 (--4.82 to 10.90)    .45         0.00
   Surgery                             284           82.65 ± 30.33                                         
   Nonsurgery                          82            85.69 ± 36.79                                         

*^a^*All tests were performed with univariate linear regression. Beta, *P* value, and *R* ^2^ value are based on original values and not on stratified groups. LSI, limb symmetry index.

###### 

Linear Regression Model With the LSI of Total Work as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table4)

  Tentative Predictor                  n             Mean LSI        Beta (95% CI)               *P* Value   *R* ^2^ Value
  ------------------------------------ ------------- --------------- --------------------------- ----------- ---------------
  Patient sex                          Missing: 0                    5.09 (--3.93 to 14.12)      .27         0.00
   Male                                314           72.81 ± 27.49                                           
   Female                              58            77.91 ± 50.43                                           
  Age (beta per 10 units), y           Missing: 0                    --2.17 (--6.01 to 1.66)     .27         0.00
   18 to \<35                          92            75.55 ± 21.56                                           
   35 to \<45                          168           73.46 ± 32.81                                           
   45 to \<55                          88            72.52 ± 28.41                                           
   55 to 71                            24            71.15 ± 62.50                                           
  Height (beta per 10 units), cm       Missing: 11                   --1.77 (--5.70 to 2.16)     .38         0.00
   153.0 to \<175.0                    110           74.13 ± 38.26                                           
   175.0 to \<183.0                    124           71.37 ± 20.48                                           
   183.0 to 200.0                      128           75.97 ± 35.29                                           
  Weight (beta per 10 units), kg       Missing: 10                   --1.33 (--3.94 to 1.27)     .31         0.00
   52.0 to \<78.0                      117           76.57 ± 38.34                                           
   78.0 to \<90.0                      121           71.70 ± 23.82                                           
   90.0 to 129.0                       125           73.41 ± 32.46                                           
  Body mass index (derived), kg/m^2^   Missing: 11                   --0.32 (--1.38 to 0.73)     .55         0.00
   19.6 to \<25.0                      146           74.21 ± 23.72                                           
   25.0 to \<30.0                      172           74.83 ± 39.81                                           
   30.0 to 43.6                        44            68.67 ± 19.67                                           
  Smoking                              Missing: 90                   --0.54 (--19.45 to 18.38)   .96         0.00
   Nonsmoker                           270           73.85 ± 35.70                                           
   Smoker                              14            73.31 ± 17.39                                           
  Treatment                            Missing: 0                    --5.00 (--12.86 to 2.86)    .21         0.00
   Surgery                             289           74.72 ± 34.96                                           
   Nonsurgery                          83            69.73 ± 18.82                                           

*^a^*All tests were performed with univariate linear regression. Beta, *P* value, and *R* ^2^ value are based on original values and not on stratified groups. LSI, limb symmetry index.

###### 

Linear Regression Model With the LSI of Number of Repetitions as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table5)

  Tentative Predictor                  n             Mean LSI        Beta (95% CI)             *P* Value   *R* ^2^ Value
  ------------------------------------ ------------- --------------- ------------------------- ----------- ---------------
  Patient sex                          Missing: 0                    1.40 (--5.22 to 8.02)     .68         0.00
   Male                                315           89.15 ± 22.94                                         
   Female                              58            90.55 ± 26.76                                         
  Age (beta per 10 units), y           Missing: 0                    0.67 (--2.13 to 3.47)     .64         0.00
   18 to \<35                          93            90.65 ± 20.16                                         
   35 to \<45                          168           86.49 ± 21.08                                         
   45 to \<55                          88            92.90 ± 24.23                                         
   55 to 71                            24            91.51 ± 42.09                                         
  Height (beta per 10 units), cm       Missing: 11                   --1.64 (--4.48 to 1.19)   .26         0.00
   153.0 to \<175.0                    111           90.12 ± 22.74                                         
   175.0 to \<183.0                    124           89.31 ± 18.86                                         
   183.0 to 200.0                      128           89.65 ± 27.17                                         
  Weight (beta per 10 units), kg       Missing: 10                   --0.97 (--2.85 to 0.91)   .31         0.00
   52.0 to \<78.0                      117           91.06 ± 22.27                                         
   78.0 to \<90.0                      122           89.34 ± 24.27                                         
   90.0 to 129.0                       125           88.86 ± 23.00                                         
  Body mass index (derived), kg/m^2^   Missing: 11                   --0.11 (--0.87 to 0.65)   .78         0.00
   19.6 to \<25.0                      146           90.43 ± 23.33                                         
   25.0 to \<30.0                      173           89.96 ± 24.15                                         
   30.0 to 43.6                        44            86.09 ± 18.42                                         
  Smoking                              Missing: 90                   5.23 (--7.80 to 18.26)    .43         0.00
   Nonsmoker                           270           88.14 ± 24.64                                         
   Smoker                              14            93.37 ± 9.02                                          
  Treatment                            Missing: 0                    1.59 (--4.16 to 7.33)     .59         0.00
   Surgery                             289           89.01 ± 24.69                                         
   Nonsurgery                          84            90.59 ± 19.15                                         

*^a^*All tests were performed with univariate linear regression. Beta, *P* value, and *R* ^2^ value are based on original values and not on stratified groups. LSI, limb symmetry index.

###### 

Logistic Regression Model With Patients in the Top 10% of the ATRS as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table6)

  Tentative Predictor                                  Missing, n   Top 10%, n (%)   OR (95% CI)        *P* Value   AUC (95% CI)
  ---------------------------------------------------- ------------ ---------------- ------------------ ----------- ------------------
  Patient sex                                          0                             0.87 (0.35-2.18)   .77         0.51 (0.45-0.57)
   Male                                                             34 (10.9)                                       
   Female                                                           6 (9.7)                                         
  Age (OR per 10 units), y                             0                             0.83 (0.57-1.23)   .36         0.55 (0.44-0.65)
   18 to \<35                                                       17 (18.3)                                       
   35 to \<45                                                       8 (4.9)                                         
   45 to \<55                                                       13 (14.6)                                       
   55 to 71                                                         2 (7.4)                                         
  Height (OR per 10 units), cm                         11                            1.22 (0.82-1.82)   .32         0.56 (0.46-0.66)
  Weight (OR per 10 units), kg                         10                            0.96 (0.75-1.23)   .75         0.51 (0.41-0.60)
  Body mass index (derived) (OR per 1 unit), kg/m^2^   11                            0.94 (0.84-1.04)   .24         0.55 (0.46-0.65)
  Smoking                                              90                            2.57 (0.68-9.71)   .16         0.53 (0.47-0.60)
   Nonsmoker                                                        22 (8.2)                                        
   Smoker                                                           3 (18.8)                                        
  Treatment                                            0                             1.00 (0.46-2.19)   \>.99       0.50 (0.43-0.57)
   Surgery                                                          31 (10.7)                                       
   Nonsurgery                                                       9 (10.7)                                        

*^a^*All tests were performed with univariate logistic regression. OR, *P* value, and AUC are based on original values and not on stratified groups. ATRS, Achilles tendon Total Rupture Score; AUC, area under the receiver operating characteristic curve; OR, odds ratio.

###### 

Logistic Regression Model With Patients in the Bottom 10% of the ATRS as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table7)

  Tentative Predictor                                  Missing, n   Bottom 10%, n (%)   OR (95% CI)        *P* Value   AUC (95% CI)
  ---------------------------------------------------- ------------ ------------------- ------------------ ----------- ------------------
  Patient sex                                          0                                0.97 (0.39-2.43)   .94         0.50 (0.44-0.57)
   Male                                                             31 (10.0)                                          
   Female                                                           6 (9.7)                                            
  Age (OR per 10 units), y                             0                                0.98 (0.66-1.45)   .92         0.50 (0.41-0.60)
   18 to \<35                                                       8 (8.6)                                            
   35 to \<45                                                       18 (11.0)                                          
   45 to \<55                                                       8 (9.0)                                            
   55 to 71                                                         3 (11.1)                                           
  Height (OR per 10 units), cm                         11                               0.81 (0.55-1.21)   .31         0.55 (0.45-0.64)
  Weight (OR per 10 units), kg                         10                               0.92 (0.71-1.20)   .53         0.52 (0.41-0.63)
  Body mass index (derived) (OR per 1 unit), kg/m^2^   11                               0.99 (0.90-1.10)   .92         0.51 (0.40-0.62)
  Smoking                                              90                               2.05 (0.55-7.66)   .28         0.52 (0.47-0.58)
   Nonsmoker                                                        27 (10.1)                                          
   Smoker                                                           3 (18.8)                                           
  Treatment                                            0                                1.52 (0.72-3.23)   .27         0.54 (0.46-0.62)
   Surgery                                                          26 (9.0)                                           
   Nonsurgery                                                       11 (13.1)                                          

*^a^*All tests were performed with univariate logistic regression. OR, *P* value, and AUC are based on original values and not on stratified groups. ATRS, Achilles tendon Total Rupture Score; AUC, area under the receiver operating characteristic curve; OR, odds ratio.

###### 

Logistic Regression Model With Patients in the Top 10% of the LSI of Heel-Rise Height as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table8)

  Tentative Predictor                                  Missing, n   Top 10%, n (%)   OR (95% CI)        *P* Value   AUC (95% CI)
  ---------------------------------------------------- ------------ ---------------- ------------------ ----------- ------------------
  Patient sex                                          0                             0.85 (0.32-2.28)   .74         0.51 (0.45-0.57)
   Male                                                             32 (10.2)                                       
   Female                                                           5 (8.8)                                         
  Age (OR per 10 units), y                             0                             0.69 (0.45-1.05)   .083        0.58 (0.49-0.67)
   18 to \<35                                                       12 (13.0)                                       
   35 to \<45                                                       18 (10.8)                                       
   45 to \<55                                                       5 (5.7)                                         
   55 to 71                                                         2 (8.3)                                         
  Height (OR per 10 units), cm                         11                            1.10 (0.72-1.66)   .67         0.55 (0.45-0.65)
  Weight (OR per 10 units), kg                         10                            0.96 (0.73-1.26)   .75         0.50 (0.40-0.61)
  Body mass index (derived) (OR per 1 unit), kg/m^2^   11                            0.95 (0.85-1.07)   .41         0.53 (0.43-0.64)
  Smoking                                              90                            1.37 (0.29-6.45)   .69         0.51 (0.46-0.55)
   Nonsmoker                                                        29 (10.8)                                       
   Smoker                                                           2 (14.3)                                        
  Treatment                                            0                             0.50 (0.19-1.34)   .17         0.55 (0.49-0.61)
   Surgery                                                          32 (11.1)                                       
   Nonsurgery                                                       5 (6.0)                                         

*^a^*All tests were performed with univariate logistic regression. OR, *P* value, and AUC are based on original values and not on stratified groups. ATRS, Achilles tendon Total Rupture Score; AUC, area under the receiver operating characteristic curve; OR, odds ratio.

###### 

Logistic Regression Model With Patients in the Bottom 10% of the LSI of Heel-Rise Height as a Dependent Outcome*^a^*

![](10.1177_2325967118813904-table9)

  Tentative Predictor                                  Missing, n   Bottom 10%, n (%)   OR (95% CI)        *P* Value   AUC (95% CI)
  ---------------------------------------------------- ------------ ------------------- ------------------ ----------- ------------------
  Patient sex                                          0                                1.28 (0.53-3.06)   .58         0.52 (0.45-0.58)
   Male                                                             31 (9.9)                                           
   Female                                                           7 (12.3)                                           
  Age (OR per 10 units), y                             0                                1.79 (1.23-2.62)   .0026       0.66 (0.57-0.75)
   18 to \<35                                                       3 (3.3)                                            
   35 to \<45                                                       16 (9.6)                                           
   45 to \<55                                                       14 (15.9)                                          
   55 to 71                                                         5 (20.8)                                           
  Height (OR per 10 units), cm                         11                               0.78 (0.52-1.15)   .21         0.57 (0.46-0.67)
  Weight (OR per 10 units), kg                         10                               0.85 (0.65-1.11)   .24         0.55 (0.44-0.66)
  Body mass index (derived) (OR per 1 unit), kg/m^2^   11                               0.96 (0.85-1.07)   .44         0.52 (0.41-0.63)
  Smoking                                              90                               0.63 (0.08-5.02)   .67         0.51 (0.47-0.54)
   Nonsmoker                                                        29 (10.8)                                          
   Smoker                                                           1 (7.1)                                            
  Treatment                                            0                                1.07 (0.48-2.35)   .87         0.51 (0.43-0.58)
   Surgery                                                          29 (10.1)                                          
   Nonsurgery                                                       9 (10.7)                                           

*^a^*All tests were performed with univariate logistic regression. OR, *P* value, and AUC are based on original values and not on stratified groups. ATRS, Achilles tendon Total Rupture Score; AUC, area under the receiver operating characteristic curve; OR, odds ratio.
